The weekly departmental seminars are given by invited guest speakers during the academic year to the Lautenberg faculty members and students together with other members of the IMRIC institute and the faculty of medicine .
Next seminar:
Tuesday February 10th, 12:00 at Hall H, 3rd floor
Two speakers:
Subject: “The virtues of restraint”
Sourav Ghosh, Dept. of Neurology, Yale University
Subject: “Death begets a new beginning”
Previuos seminars:
Dr. Ulus Atasoy
Chief, Division of Allergy-Immunology, Ann Arbor VA Health System
Tuesday February 6th, 12:00 at Rubin Hall
Subject: Post-transcriptional control of CD4+ T cell differentiation and function in inflammation
Dr. Livnat Jerby-Arnon
The Broad Institute of MIT and Harvard
Tuesday January 21st, 2020
Subject: Dissecting immune evasion mechanisms in cancer using single-cell technologies
Dr. Eric Shifrut
Department of Microbiology and Immunology, University of California San Francisco
Tuesday December 14st, 2019
Subject: Engineering human T cell therapies using CRISPR discovery platforms
Prof. Meromit Singer
cBio Center, Dana-Farber Cancer Institute, Department of Immunology, Harvard Medical School
Tuesday December 31st, 2019
Subject: From characterization towards function: Analysis of tissue-derived single-cell RNA-seq data
Ms. Ela Zino
The Concern Foundation Laboratories at the Lautenberg center for immunology and cancer research
Tuesday December 25th 2019
Subject: CCL20 in Liver Inflammation and Carcinogenesis
Prof. Yaron Carmi
Tel-Aviv University, School of Medicine
Tuesday December 17th, 2019
Subject: Melanoma-secreted lysosomes trigger monocyte-derived dendritic cell apoptosis and limit cancer immunotherap
Prof. Eynav Klechevsky
Department of Pathology & Immunology Washington University School of Medicine, MO, USA
Tuesday December 3rd 2019
Subject: Upstream regulation of autoimmunity and cancer via human dendritic cell subset
Prof. Magdalena Huber
Philipps University of Marburg. Institut für Medizinische Mikrobiologie und Krankenhaushygiene
November 26, 2019.
Subject: T cells in health and disease
Prof. Liran Carmel
The Alexander Silberman Institute of Life Sciences The Hebrew University
November 19th, 2019.
Subject: Using ancient DNA methylation to reconstruct the anatomy of the elusive Denisovan
Prof. Aladár A Szalay
Director of Cancer Therapy Research Center, Institute of Biochemistry
University of Wuerzburg, Germany and UCSD Cancer Center, CA, USA
November 12th, 2019.
Subject: Autologous stem cells as oncolytic small pox vaccine carriers for immunotherapy of cancer in human patients
Dr. Oren Ram
Faculty of Life Sciences, Bar-Ilan University
November 5th, 2019
Subject: Cellular heterogeneity is regulated by enhancer methylation patterns
Dr. Ofir Hakim
Faculty of Life Sciences, Bar-Ilan University
October 29th
Subject: genomic retargeting of p53 and CTCF in oncogenesis
Prof. Yariv Wine
Department of molecular genetics, Tel Aviv University
June 4th, 2019.
Subject: Next Generation Sequencing and Proteomics for Antibody Repertoire analysis and Antibody Discovery
Prof. Noam GInossar
Department of molecular genetics, The Weizmann Institute
May 21th, 2019.
Subject: HCMV Latent Infection- Lessons from Single Cell Analyses
Prof. Mordechay (Motti) Gerlic
Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University
April 30th, 2019.
Subject: Communication between necroptotic cells and their surrounding
Dr. Ziv Shulman
Weizmann Institute of Science
April 16th, 2019.
Subject: Dynamics of B cell immune responses in intestinal tissues
Dr. Ronen Hazan
The institute of Dental Science, HUJI
March 19th, 2019. at 12:10 (Refreshments at 12:00), Hall “Z” (אולם ז), third floor.
Subject: the promise of phage therapy
Dr. Jakub Abramson
Department of Immunology, Weizmann Institute of Science
March 12th, 2019.
Subject: Thymic tuft cells
Prof. Vered Padler-Karavani
Department of Cell Research and Immunology, TAU
February 26th, 2019.
Subject: Immunological responses against glycosylated biotherapeutics and biodevices in humans
Prof. Eyal Gottlieb
Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology
February 19th, 2019.
Subject: Metabolic liabilities of TCA cycle truncated tumors
Dr. Dina Schneidman
Department of Biological Chemistry, Institute of Life Sciences, School of Computer Science and Engineering, HUJI
February 12th, 2019.
Subject: Predicting epitopes using integrative structure modeling
Dr. Yanay Ofran
Head – Systems Biology & Functional Genomics, Mina and Everard Goodman Faculty of Life Sciences
February 5th, 2019.
Subject: Computational Design of antibodies
Dr. Ariel Munitz
Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University
December 25th, 2018.
Subject: Emerging Roles For Eosinophils in the Tumor microenvironment
Dr. Leeat Keren
Stanford University School of Medicine
October 23rd 2018
Subject: Unraveling the tumor immune microenvironment using multiplexed imaging.
Dr. Arthur A. Vandenbark
Portland VA Medical Center, Oregon Health & Science University
October 9th, 2018.
Subject: MIF-CD74 interactions
Prof. Yardena Samuels
Dept. of Molecular Cell Biology, Weizmann Institute of Science
June 26, 2018
Towards deciphering the neo-antigenic and T cell receptor landscapes in melanoma.
Dr. Tal Shai
Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva
June 5, 2018
Identifying differential splicing in the immune system from RNA sequencing data
Dr. Irit Gat-Viks
School of Molecular Cell Biology and Biotechnology, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University
May 29, 2018
Revealing the immune basis of disease: a computational approach
Dr. Tal Burstyn-Cohen
Institute for Dental Sciences Hebrew University-Hadassah Jerusalem, Israel
May 22, 2018
PROS1 inhibits tumor metastasis by curbing inflammation
Prof. Steffen Jung
Department of Immunology Weizmann Institute of Science
May 1, 2018
Not just glue – Studying Microglia
Prof. Neta Erez
Sackler School of Medicine Tel Aviv University
April 10, 2018
Cancer-Associated Fibroblasts Link Tissue Damage with Tumor Promoting Inflammation in Breast Cancer
Prof. Francesco Colucci
Department of Obstetrics and Gynaecologyand Centre for Trophoblast Research University of Cambridge, England
March 13, 2018
Maternal innate lymphocytes regulatefetal development
Prof. Johan K. Sandberg
Center for Infection Medicine Department of Medicine Karolinska Institute Karolinska University Hospital Huddinge, Sweden.
Feb 15, 2018
Human MAIT cells in health and disease
Dr. Gal Cafri:
Surgery Branch
National Cancer Institute, Bethesda USA
July 4, 2017
Immunotherapeutic targeting of somatic mutations in human cancers
Prof. Ygal Haupt:
Tumour Suppression Laboratory
The Peter MacCallum Cancer Center, Melbourne, Australia
June 28, 2017
Restoration of tumour suppression in hormone related cancers
Prof. Shai Izraeli:
Department of Molecular Genetics & Biochemistry
Sackler Faculty of Medicine, Tel Aviv University
May 23, 2017
Prof. Gidi Rechavi:
The Sheba Cancer Center
Sheba Medical Center Hospital- Tel Hashomer, Ramat Gan
May 16, 2017
Prof. Yossi Shiloh:
Department of Human Molecular Genetics & Biochemistry
Sackler School of Medicine,Tel Aviv University, Israel
May 9, 2017
The DNA damage response: a matter of checks and balances
Dr. Arthur Machlenkin:
Head of Immunology Group at Compugen
Holon, Israel
April 25, 2017
Dr. Eyal Raz:
Division of Rheumatology, Allergy & Immunology
University of California San Diego, USA
April 18, 2017
Dr. Yaqub Hanna:
Department of Molecular Genetics
Weizmann Institute of Science, Rehovot, Israel
March 21, 2017
Molecular Mechanisms Regulating Deterministic Induction of Naïve Pluripotency
Prof. Adit Ben-Baruch:
Department of cell Research and Immunology
Tel Aviv University, Israel
March 7, 2017
The cholinergic tradeoff of stress micromanagement
Prof. Yuval Shaked:
Nano Biotechnology and Nanomedicine
Technion Institute of Technology, Haifa, Israel
Febuary 28, 2017
Breakthrough in Targeting the Cancer Immunome
Dr. Igor Ulitsky:
Department of Biological Regulation
Weizmann Institute of Science, Rehovot, Israel
January 31, 2017
Functions and Modes of Action of Long Noncoding RNAs in Mammalian Cells.
Prof. Michal Schwartz:
Neuroimmunology
Weizmann Institute of Science, Rehovot, Israel
January 24, 2017
Harnessing adaptive immunity by immune checkpoint blockade for fighting Alzheimer’s disease.
Dr. Noga Ron Harel:
Department of Cell Biology
Harvard Medical School, Boston, MA, USA
January 17. 2017
Fueling immunity: mitochondrial rewiring drives anabolic metabolism for T cell activation.
Dr. Amir Orian:
Polak Cancer Center, Rappaport Faculty of Medicine
Technion Institute of technology, Haifa, Israel
January 10, 2017
Specifiction and maintenance of enterocytes identity
Dr. Michal Goldberg:
The Department of Genetics, The Alexander Silberman Institute of Life Sciences
The Hebrew University, Jerusalem, Israel
January 3, 2017
Spironolactone – a novel role for FNA approved drug in cancer theraphy
Dr. Michal Lotem:
Melanoma and Cancer Immunotherapy
The Hebrew University, Jerusalem, Israel
December 27, 2016
SLAMF6- a novel modulatory receptor for anti-tumor immunotherapy
Dr. Asaf Spiegel:
Whitehead Institute for Biomedical Research
Cambridge, MA, USA
December 20, 2016
Immune Cell Regulation of the Metastatic Niche- Survival, Extravasation and Beyond.
Dr. Gary J. Nabel:
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Maryland, USA
December 8, 2016
Harnessing Novel Immune Technologies Against Influenza, HIV and Cancer
Dr. Hermona Soreq:
The Center for Brain Sciences
The Hebrew University, Jerusalem, Israel
November 29, 2016
The cholinergic tradeoff of stress micromanagement
Dr. Cyril Cohen:
Laboratory of Tumor Immunology and Immunotherapy
Bar Ilan University, Ramat Gan, Israel
November 22, 2016
T-cell anti-tumor immunity-bridging between personalized medicine and immunotherapy